Literature DB >> 10435647

Effects of red blood cell transfusion on resting energy expenditure in adolescents with sickle cell anemia.

P Harmatz1, M B Heyman, J Cunningham, P D Lee, L Styles, K Quirolo, L Kopp-Hoolihan, J Ghiron, R L Hintz, E Vichinsky.   

Abstract

BACKGROUND: Previous studies indicate that resting energy expenditure is elevated in children with sickle cell anemia, possibly caused in part by hemolysis and increased erythropoietic activity. The purpose of the present investigation was to determine whether erythrocyte transfusion normalizes resting energy expenditure in sickle cell anemia.
METHODS: Five adolescents with sickle cell anemia (12-16 years old; 4 boys, 1 girl) were studied before and 1 week after erythrocyte transfusion before elective surgery or at the initial transfusion for growth failure. Resting energy expenditure was measured by indirect calorimetry, and laboratory measures were determined by routine, validated methods. Data comparisons were by nonparametric analysis.
RESULTS: After erythrocyte transfusion, total hemoglobin levels increased (difference (D) = 15 g/l; p < 0.05), whereas hemoglobin S (D = -0.36; p < 0.05) and reticulocyte count (D = -0.12; p < 0.05) decreased. Mean pretransfusion resting energy expenditure was elevated to 124% above predicted levels (p < 0.05) and increased further to 134% above prediction (p < 0.05 vs. pretransfusion levels). Plasma triiodothyronine (T3) levels increased (D = 0.17 nmol/l; p < 0.05), reverse T3 (rT3) levels tended to decline (D = -0.04 nmol/l; p = 0.14), and rT3/T3 decreased (D = -0.03; p < 0.05). Plasma insulin-like growth factor-I (IGF-I) levels were low-normal before transfusion and did not change, despite the change in resting energy expenditure.
CONCLUSIONS: The results confirm that resting energy expenditure is elevated in patients with sickle cell anemia. However, resting energy expenditure further increased after transfusion, despite decreased erythropoietic activity. A posttransfusion decrease in rT3/T3 may contribute to the increased resting energy expenditure. That there was no change in IGF-I implies that the growth hormone-IGF system is not involved in posttransfusion regulation of resting energy expenditure. Therefore, our data are not consistent with the hypothesis that increased resting energy expenditure in sickle cell anemia is directly related to erythropoietic activity. The mechanisms by which resting energy expenditure increases after transfusion in sickle cell anemia require additional investigation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10435647     DOI: 10.1097/00005176-199908000-00006

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  5 in total

1.  Erythropoiesis and myocardial energy requirements contribute to the hypermetabolism of childhood sickle cell anemia.

Authors:  Jacqueline M Hibbert; Melissa S Creary; Beatrice E Gee; Iris D Buchanan; Alexander Quarshie; Lewis L Hsu
Journal:  J Pediatr Gastroenterol Nutr       Date:  2006-11       Impact factor: 2.839

2.  Nutritional deficiencies in iron overloaded patients with hemoglobinopathies.

Authors:  Susan Claster; John C Wood; Leila Noetzli; Susan M Carson; Thomas C Hofstra; Rachna Khanna; Thomas D Coates
Journal:  Am J Hematol       Date:  2009-06       Impact factor: 10.047

3.  The association of transfusion status with antioxidant enzymes and malondialdehyde level in Nigerians with sickle cell disease.

Authors:  Emokpae Mathias Abiodun; Kuliya-Gwarzo Aisha
Journal:  Asian J Transfus Sci       Date:  2014-01

4.  Selenium and Vitamin E as antioxidants in chronic hemolytic anemia: Are they deficient? A case-control study in a group of Egyptian children.

Authors:  Mona M Hamdy; Dalia S Mosallam; Alaa M Jamal; Walaa A Rabie
Journal:  J Adv Res       Date:  2015-01-13       Impact factor: 10.479

5.  Wasting and stunting are still prevalent in children with sickle cell anaemia in Lagos, Nigeria.

Authors:  Christopher I Esezobor; Patricia Akintan; Adebola Akinsulie; Edamisan Temiye; Titilope Adeyemo
Journal:  Ital J Pediatr       Date:  2016-05-04       Impact factor: 2.638

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.